methyl protodioscin has been researched along with Cancer of Mouth in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, JC; Chen, MK; Chien, SY; Chuang, YC; Hsi, YT; Hsieh, MJ; Lin, CC; Lin, CW; Lo, YS; Yang, SF | 1 |
1 other study(ies) available for methyl protodioscin and Cancer of Mouth
| Article | Year |
|---|---|
Inhibition of cathepsin S confers sensitivity to methyl protodioscin in oral cancer cells via activation of p38 MAPK/JNK signaling pathways.
Topics: Apoptosis; Autophagy; Cathepsins; Cell Cycle Checkpoints; Cell Death; Cell Line, Tumor; Cell Survival; Diosgenin; Humans; MAP Kinase Signaling System; Mouth Neoplasms; Saponins | 2017 |